Solifenacin Succinate Versus Tolterodine 4mg Once Daily

Clinical trial NCT00802373 · COMPLETED

Trial details

NCT number: NCT00802373
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2003-07-01
Primary completion: 2004-10-01
Enrollment: 1355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.